The Physical Experience
A hot flash, the most recognised symptom of menopause and perimenopause, is described differently by different women, but most accounts share a core pattern: a sudden, intense wave of heat that spreads rapidly through the upper body, face, and neck, often accompanied by visible reddening of the skin (flushing), sweating, a racing or fluttering heartbeat, and a feeling of pressure or warmth that can be mild, uncomfortable, or overwhelming.
The experience typically begins with a brief prodrome, a sensation of heat building in the chest or solar plexus, sometimes described as a pressure or a warning signal, before the wave of heat moves upward through the neck and into the face. Some women describe the forehead, cheeks, and scalp becoming intensely hot to the touch. Sweating can range from a light dampness to drenching perspiration. The heart may beat visibly faster. Some women feel dizzy, nauseous, or anxious during the peak of a hot flash. Others describe a feeling of needing to remove clothing, open windows, or physically escape from their environment.
The duration varies. Most hot flashes last between one and five minutes, though longer episodes of up to ten minutes are not uncommon, particularly early in the menopausal transition. After the heat peaks, many women experience a rapid chill as body temperature drops, occasionally shivering even in warm environments. This contrast between the intense heat and the subsequent chill is one of the most disorienting aspects of the experience for many women.
What Is Happening in the Body
Hot flashes are vasomotor symptoms, meaning they involve a rapid change in blood vessel tone driven by the body’s thermoregulatory system. The current scientific understanding centres on a group of neurons in the hypothalamus (the brain’s temperature control centre) called KNDy neurons, which co-release three neuropeptides: kisspeptin, neurokinin B, and dynorphin. In women with adequate estrogen, these neurons help maintain a stable thermoneutral zone, the internal temperature range within which the body does not trigger cooling responses such as sweating and blood vessel dilation.
As estrogen declines during perimenopause, the thermoneutral zone narrows. Even minor fluctuations in core body temperature, a warm room, physical exertion, a hot drink, stress, alcohol, spicy food, or simply lying still under blankets, can be interpreted by the hypothalamus as overheating, triggering an emergency cooling response. That response is a hot flash: rapid dilation of peripheral blood vessels, a surge of blood to the skin surface, sweating, and an activation of the sympathetic nervous system that causes the elevated heart rate.
Neurokinin B, one of the three neuropeptides released by KNDy neurons, is now understood to be critical in initiating this cascade. This discovery has led to the development of a new class of treatments, NK3 receptor antagonists, which work by blocking the neurokinin B signal. These medications represent the first entirely non-hormonal pharmaceutical approach to hot flash management.
Frequency and Patterns
Hot flashes vary enormously in frequency. Some women experience one or two mild flashes per week; others report 20 or more per day. On average, women experience between seven and ten hot flashes daily at peak severity. They can occur at any time but are particularly common in the late evening and early morning hours, frequently disrupting sleep.
Night sweats are hot flashes that occur during sleep. They are physiologically identical to daytime hot flashes but have an outsized impact on sleep quality because they interrupt deep and REM sleep stages. Women who experience frequent night sweats often accumulate significant sleep debt over weeks and months, contributing to the fatigue, cognitive difficulty, and mood changes that are prominent features of perimenopause.
Hot flashes typically begin in perimenopause and, for most women, become most intense in the years immediately before the final menstrual period and the year or two following. However, population data shows that approximately 35% of women continue to experience vasomotor symptoms for more than ten years after their final period.
What Helps
Multiple evidence-based options exist for reducing hot flash frequency and severity. Hormone replacement therapy (HRT) remains the most effective pharmaceutical intervention, reducing hot flash frequency by 75–90% in most women. Non-hormonal prescription options include certain antidepressants (SNRIs and SSRIs at specific doses), gabapentin, clonidine, and the newer NK3 receptor antagonists such as fezolinetant.
Lifestyle modifications with meaningful supporting evidence include keeping the sleep environment cool (below 18°C/65°F), reducing alcohol and caffeine intake, managing stress through nervous system regulation practices, and avoiding personal triggers when identified.
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any changes to your health management.